| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | HLGN | Common Stock | Sale | $672,072 | -442,298 | -100% | $1.52 | 0 | 15 Feb 2024 | Direct | F1 |
| holding | HLGN | Common Stock | 142,313 | 15 Feb 2024 | See footnote | F2 | |||||
| holding | HLGN | Common Stock | 462 | 15 Feb 2024 | See footnote | F3 |
| Id | Content |
|---|---|
| F1 | Non-market, private transaction pursuant to a stock transfer between Idealab Holdings, LLC ("Idealab Holdings") and an affiliate of an existing holder of the Issuer's common stock. Price represents agreed value per share of non-cash consideration received in transfer. Idealab Holdings, which is a wholly owned subsidiary of Idealab, a California corporation ("Idealab"). Idealab is managed by a board of directors (the "Idealab Board") including Mr. Gross. Mr. Gross may be deemed to have beneficially own these shares. Mr. Gross disclaimed beneficial ownership of these shares except to the extent of his pecuniary interest therein. Stock transferred on 2/20/2024. |
| F2 | These shares are held by The Gross Goodstein Living Trust (the "Trust") of which Mr. Gross is a co-trustee. Mr. Gross may be deemed to beneficially own these shares. Mr. Gross disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. |
| F3 | These shares are held by Idealab Studio, LLC ("Idealab Studio"), for which Mr. Gross serves as chairman and chief executive officer. The Trust owns a majority of the class of securities of Idealab Studio entitled to elect two managers to Idealab Studio's board of managers. Mr. Gross may be deemed to beneficially own these shares. Mr. Gross disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. |